Biological Threat Detection Via Host Gene Expression Profiling. Biological Threat Detection Via Host Gene Expression Profiling.

Biological Threat Detection Via Host Gene Expression Profiling‪.‬

Clinical Chemistry 2003, July, 49, 7

    • 2,99 €
    • 2,99 €

Description de l’éditeur

The task of detecting biological threats is far more complicated than monitoring for other weapons of mass destruction. Measuring and quantifying radiation and chromatographic profiles indicative of nuclear and chemical threats, respectively, are relatively straightforward compared with the detection of biological weapon threats amid the tremendous biological background that comprises our environment. Most of the current biological warfare and environmental agent detection systems in field use or under prototype development rely on structural recognition approaches to identify anticipated agents or rely on "gold standard" culture conditions. Such assays, based primarily on antibodies, are highly specific for anticipated targets but provide only partial information concerning the pathogenicity of the threat. Current systems the military has implemented for threat identification have performed with limited success. In fact, the Pentagon Inspector General has criticized the "Joint Biological Point Detection System" for erratic limited performance (1). In addition, it is unclear how such an approach is applicable to the civilian population, where mass deployment of point detectors is not a feasible solution. Even with ideal detectors, proximity to a biological threat does not guarantee infection or illness. For threats such as Bacillus anthracis, the ability to preemptively treat individuals who were near dissemination sources with antibiotics is an option, if the dissemination source can be identified. Of further concern, a report has been published of a B. anthracis vaccine strain that had been engineered by Russian scientists to resist tetracycline antibiotics (2), raising the possibility that a quinolone-resistant B. anthracis could emerge as a biological weapon threat. Thus, not all biological threats can be treated as readily as during recent events, and there is a critical need to be able to quickly discern those individuals who are ill as a result of a bioagent etiology and to yield insight to the severity of illness.

GENRE
Science et nature
SORTIE
2003
1 juillet
LANGUE
EN
Anglais
LONGUEUR
15
Pages
ÉDITIONS
American Association for Clinical Chemistry, Inc.
DÉTAILS DU FOURNISSEUR
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
TAILLE
171,6
Ko
Gene Discovery for Disease Models Gene Discovery for Disease Models
2011
Chemical Diagnostics Chemical Diagnostics
2013
Molecular Analysis and Genome Discovery Molecular Analysis and Genome Discovery
2011
Omics Approaches, Technologies And Applications Omics Approaches, Technologies And Applications
2019
Systems Biological Approaches in Infectious Diseases Systems Biological Approaches in Infectious Diseases
2007
Integration of Omics Approaches and Systems Biology for Clinical Applications Integration of Omics Approaches and Systems Biology for Clinical Applications
2018
Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers) Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers)
1998
Distribution of Adiponectin, Leptin, And Metabolic Correlates of Insulin Resistance: A Longitudinal Study in British Children; 1: Prepuberty (Earlybird 15) (Endocrinology and Metabolism) (Clinical Report) Distribution of Adiponectin, Leptin, And Metabolic Correlates of Insulin Resistance: A Longitudinal Study in British Children; 1: Prepuberty (Earlybird 15) (Endocrinology and Metabolism) (Clinical Report)
2008
The MALDI-TOF Mass Spectrometric View of the Plasma Proteome and Peptidome. The MALDI-TOF Mass Spectrometric View of the Plasma Proteome and Peptidome.
2006
Interlaboratory Comparison of Fetal Male DNA Detection from Common Maternal Plasma Samples by Real-Time Pcr (Molecular Diagnostics and Genetics) Interlaboratory Comparison of Fetal Male DNA Detection from Common Maternal Plasma Samples by Real-Time Pcr (Molecular Diagnostics and Genetics)
2004
Ghrelin, Leptin, IGF-1, IGFBP-3, and Insulin Concentrations at Birth: Is There a Relationship with Fetal Growth and Neonatal Anthropometry?(Pediatric Clinical Chemistry) Ghrelin, Leptin, IGF-1, IGFBP-3, and Insulin Concentrations at Birth: Is There a Relationship with Fetal Growth and Neonatal Anthropometry?(Pediatric Clinical Chemistry)
2008
Association of Increased Ferritin with Premature Coronary Stenosis in Men (Lipids, Lipoproteins, And Cardiovascular Risk Factors) Association of Increased Ferritin with Premature Coronary Stenosis in Men (Lipids, Lipoproteins, And Cardiovascular Risk Factors)
2001